Director, Pharmacology & Toxicology

San Clemente, United States

Glaukos

Posted on: October 8, 2020

Closing: November 07, 2020

Salary: Undisclosed

Position Type: Full Time

Job Description

The Director, Pharmacology and Toxicology, based in San Clemente, CA provides scientific direction for the nonclinical strategy including, pharmacology, preclinical toxicology, pharmacokinetics/pharmacodynamics studies to enable the pharmaceutical drug and combination product development and the submission of INDs, IMPDs, NDAs and MAAs in accordance with regulatory expectations for novel small and large molecule ophthalmic therapeutics and extended duration drug delivery systems.

This individual will report to the Vice President of R&D for Pharmaceutical Combination Products and lead a team of experienced scientists responsible for the design, execution, and interpretation of the nonclinical ADME-PK and safety studies conducted in the relevant toxicological species and assures that the nonclinical program supports the clinical development plan including the assessment of clinical pharmacology (systemic drug exposures, potential biomarker evaluations, in vitro in vivo correlations).

The individual will work closely with the early research teams, cross-functional project teams, regulatory, and clinical to coordinate and manage nonclinical activities that expedite the entry of target candidates into clinical trials and to provide continued support to clinical candidates.  These include planning, and execution of external GLP toxicology and non-GLP PK, PK/PD and tolerability studies to support development programs.  Reviews, summarizes and integrates complex data sets across multiple disciplines.

Mentors direct reports in the development of relevant animal models for efficacy and safety and design of studies generation of quality research reports and integrated summaries included in the regulatory submissions.

Manages, directly and as a supervisor, the preparation and presentation of nonclinical safety data for project teams, portfolio management presentations, and internal /external partners and scientific groups.  Provides strategic advice to project teams and senior management including evaluation of conclusions and potential impact of results on program and clinical/regulatory strategy.

He/she will oversee the contract research organizations (CROs), the related study monitoring activities, plans and manages the nonclinical study budgets and assures timely and compliant delivery of external study reports.  Partner and network with nationally and internationally recognized leaders/consultants

Essential Functions:

·  The ability to develop, execute, and lead a sound science-based nonclinical pharmacology, PK/PD and toxicology plan to support clinical development is a critical part of this position.

·  Design scientific approaches and use best industry practices in nonclinical toxicology and PK, PK/PD study designs.

·  Possess a broad technical experience/expertise across the following disciplines: ophthalmic drug development for the front and back of the eye, (NCEs and biologics), knowledge of relevant animal models, maintain and develop understanding of pharmacology, toxicology and the related disciplines in ADME-PK and bioanalytical.

·   Manage authors and/or the assembly of expertise specifically nonclinical sections of regulatory filings

·  Provide strong technical leadership and activity management with CROs and assure that testing activities are in compliance with current GLP and regulatory requirements

·   Ensure all development reports are completed timely to support regulatory filings.

·  Collaborates effectively within Applied Research, and with Vision ID, Clinical, Regulatory, CMC.

·  Strategically manages the team in response to project load leveraging internal and external resources

·   Directly and indirectly manage staff with coaching, goal-setting, and performance assessment.

·  Maintains current understanding of regulatory requirements and FDA and ICH guidances for the conduct of nonclinical assessments enabling 505(b)1 and 502(b) 2 regulatory strategies.

Preferred Experience:

·  15 years industry experience in a field related to nonclinical drug development in the preferred area of pharmacology/toxicology and/or related scientific discipline that includes basic biologic sciences and drug disposition.

·  The ideal candidate has current DABT certification

·  Previous experience in areas of ophthalmology with an understanding of corresponding animal models of disease and associated translational aspects of drug development is desirable.

·  Experience in designing, monitoring, interpreting and effectively communicating results of nonclinical safety studies and managing study budgets.

·  Experience in developing pharmacology/toxicology program to support early and later stage drug development and in preparing regulatory filings such  as INDs/CTAs/NDAs/MAA

·  Strong understanding of compliance guidance documents and GLP regulations

·  Excellent verbal and written communication skills

·  Previous experience and excellence in managing people, both directly and cross-functionally, and creating teams to support nonclinical programs.

·  Problem solving and organizational skills with attention to detail.

·  Strong team player and strong motivational skills.

·  Must be able to critically evaluate written and published pharmacology/toxicology documents for overall quality and acceptability of scientific interpretations.

Education:

·  Bachelors Degree and  Ph.D., postdoctoral training

 

Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex including sexual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law.

ABOUT US

Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to transform the treatment of glaucoma, one of the world’s leading causes of blindness.

The company pioneered Micro-Invasive Glaucoma Surgery, or MIGS, in order to revolutionize the traditional glaucoma treatment and management paradigm. Glaukos launched the iStent®, its first MIGS device, in the United States in 2012 and is leveraging its platform technology to build a comprehensive and proprietary portfolio of micro-scale injectable therapies designed to address the complete range of glaucoma disease states and progression.

The company’s second-generation MIGS device, the iStent inject® Trabecular Micro-Bypass System, was approved by the Food and Drug Administration, or FDA in June 2018. The company believes the iStent inject,® measuring 0.23 mm wide and 0.36 mm long, is the smallest medical device ever approved by the FDA.

In June 2015, Glaukos completed an initial public offering and our shares are now traded on the New York Stock Exchange under the ticker symbol “GKOS”. The company was founded in 1998 and is based in San Clemente, California.

Glaukos

Posted on: October 8, 2020

Closing: November 07, 2020

Salary($): Undisclosed

Position Type: Full Time

To view the entire job posting or to apply for this position, join the Xtalks community for free. Advance your career, get access to industry webinars, articles, videos, and more.

Career Focus: Pharmacology, Toxicology

Similar Jobs


Seattle, United States

Associate Scientist, Pharmacology

Zymeworks is a clinical-stage biopharmaceutical company dedicated to the...

Burlington, United States

Principal Scientist, Formulation

How will you make an impact? The Principal Formulation Scientist, based ...

Durham, United States

Clinical Pharmacologist

COMPANY: BioCryst Pharmaceuticals discovers novel, oral, small-molecule ...

Durham, United States

Pharmacometrician

COMPANY: BioCryst Pharmaceuticals discovers novel, oral, small-molecule ...